Inamed promises higher EPS (earnings per share) despite lower sales:
This article was originally published in Clinica
Inamed, a manufacturer of products for the plastic and reconstructive surgery, and obesity markets, says its sales will be lower than its mid-quarter sales update. However, second-quarter earnings per share will be at the higher end of analyst expectations, the Santa Barbara, California company says. Inamed has achieved higher earnings because it had been able to control costs. Sales were down because of the strong dollar, weaker economies in Japan and Europe, and continued weakness in the US economy.